Skip to content
PubMed This is a summary of 77 peer-reviewed journal articles Updated
Infectious Disease · HIV-Associated Neurocognitive Disorder

HIV-Associated Neurocognitive Disorder (HAND) and Dementia: A Patient Guide

At a Glance

Modern antiretroviral therapy makes severe HIV-associated dementia less common, but HIV-associated neurocognitive disorder can still cause slowed thinking, poor focus, or brain fog. A full assessment can identify HIV-related and treatable contributors and guide rehabilitation and safety support.

Living with HIV today means managing a long-term health condition with the help of powerful medications that protect both your body and your brain. While many people worry that HIV will eventually lead to severe memory loss, the reality in the era of modern antiretroviral therapy (ART) is much more encouraging. Most cognitive changes associated with the virus, collectively known as HIV-Associated Neurocognitive Disorder (HAND), are mild and do not prevent people from living independent, full lives. Severe dementia has become rare because consistent treatment keeps the virus from causing significant damage to the nervous system [1].

However, population-level statistics do not predict your individual outcome. If you are already experiencing symptoms or have been diagnosed with HIV-Associated Dementia (HAD), it is important to know that while HAD is a serious diagnosis, it does not mean an inevitable, rapid decline. People with established impairment can often stabilize with a tailored treatment, rehabilitation, and safety plan [2].

HAND is best understood as a spectrum of changes that typically affect how your brain processes information rather than just your ability to remember facts. You might feel a bit slower to react, find it harder to focus on complex tasks, or struggle to organize your daily schedule. Because these symptoms can be subtle and can fluctuate based on your stress levels or sleep, a formal diagnosis requires more than a quick office screening. It involves a clinical assessment of your history, your ability to perform daily tasks, and a review of other health factors, often accompanied by a comprehensive evaluation by specialists who look at various “domains” of thinking—such as attention and motor coordination—while accounting for your age, education, and life experiences to ensure an accurate picture of your health [3].

The core of managing brain health is maintaining total suppression of the virus through consistent ART, which allows the brain’s immune system to stabilize. However, because the brain is sensitive to everything happening in the body, “treating” HAND also means looking at the bigger picture. Issues like depression, anxiety, high blood pressure, and sleep disorders can often mimic or worsen cognitive symptoms. By identifying and treating these “look-alike” conditions, many people find that their mental clarity improves significantly [4].

Navigating these changes can be a vulnerable experience, but you are not alone. With the right care team, a commitment to your medication, and a focus on overall wellness, you can take active steps to keep your brain resilient. Protecting your independence and quality of life is a collaborative process, rooted in the understanding that modern HIV care is designed to support your health from head to toe.

Common questions in this guide

What is HIV-associated neurocognitive disorder, or HAND?
HAND is a range of changes in thinking, attention, processing speed, or daily functioning that can occur with HIV. It can be mild, while HIV-associated dementia is the most severe form; modern treatment has made severe dementia less common.
Can cognitive problems happen when HIV is suppressed?
Yes, cognitive symptoms can still occur even when treatment has suppressed the virus, but they are not automatically caused by HIV. Depression, anxiety, high blood pressure, sleep problems, stress, and medication effects can mimic or worsen brain fog, so a clinician should look for all possible contributors.
What symptoms might HIV-associated dementia cause?
People may notice slower reactions, difficulty concentrating on complex tasks, trouble organizing schedules, brain fog, or memory slips. Symptoms can be subtle and may change with stress or sleep.
How do clinicians diagnose HAND?
Diagnosis usually combines medical and HIV history with a review of daily functioning and a comprehensive cognitive assessment rather than a brief screening alone. Specialists may examine attention, processing, and motor skills while considering age, education, and life experiences.
How is HIV-associated dementia treated?
Consistent antiretroviral therapy that keeps HIV suppressed is central to managing HAND. Care may also include treating depression, anxiety, high blood pressure, or sleep disorders, along with rehabilitation and a safety plan to support independence.
Can someone with HIV-associated dementia remain independent?
A diagnosis of HIV-associated dementia does not necessarily mean rapid or inevitable decline. With individualized treatment, rehabilitation, safety planning, and support from a care team, some people can stabilize and protect their independence and quality of life.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Dementia associated with AIDS.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given that my blood tests show the virus is suppressed, what is the most likely cause of my current cognitive symptoms?
  2. 2.How can we determine if my memory concerns are related to my HIV, my mood, or my other health conditions like blood pressure?
  3. 3.What are the next steps to get a functional and cognitive assessment rather than just a quick screening?
  4. 4.Are there lifestyle changes or specific medications I am taking that might be making my 'brain fog' worse?

References

References (4)
  1. 1

    Global prevalence and burden of HIV-associated neurocognitive disorder: A meta-analysis.

    Wang Y, Liu M, Lu Q, et al.

    Neurology 2020; (95(19)):e2610-e2621 doi:10.1212/WNL.0000000000010752.

    PMID: 32887786
  2. 2

    Effect of HIV Subtype and Antiretroviral Therapy on HIV-Associated Neurocognitive Disorder Stage in Rakai, Uganda.

    Sacktor N, Saylor D, Nakigozi G, et al.

    Journal of acquired immune deficiency syndromes (1999) 2019; (81(2)):216-223 doi:10.1097/QAI.0000000000001992.

    PMID: 30865184
  3. 3

    Multimodal Approach to Neurocognitive Function in People Living with HIV in the cART Era: A Comprehensive Review.

    Moschopoulos CD, Stanitsa E, Protopapas K, et al.

    Life (Basel, Switzerland) 2024; (14(4)) doi:10.3390/life14040508.

    PMID: 38672778
  4. 4

    Neuropathogenesis of human immunodeficiency virus infection.

    Sillman B, Woldstad C, Mcmillan J, Gendelman HE

    Handbook of clinical neurology 2018; (152()):21-40 doi:10.1016/B978-0-444-63849-6.00003-7.

    PMID: 29604978

This page provides general information about HAND and HIV-associated dementia, but it is not medical advice. Talk with your HIV clinician or another qualified healthcare professional about new or worsening cognitive symptoms.